ERBB2 and breast cancer: The highest relative risk of BC death was observed for women with the least common subtype, HER2-enriched, for whom HR was 2.1 (95% CI: 1.23 to 3.59) for those living in the most deprived areas compared to women living in the least deprived areas of Scotland.